We are live on ! Find out more
GH

GAM Holding Portfolio holdings

AUM $1.57B
1-Year Est. Return 25.73%
This Fund
S&P 500
This Quarter Est. Return
+24.7%
1 Year Est. Return
+25.73%
3 Year Est. Return
+139.18%
5 Year Est. Return
+157.55%
10 Year Est. Return
+644.43%
AUM
$1.61B
AUM Growth
+$138M
Cap. Flow
-$148M
Cap. Flow %
-9.22%
Top 10 Hldgs %
24.96%
Holding
386
New
60
Increased
63
Reduced
163
Closed
63

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$18.2M
2
NTES icon
NetEase
NTES
+$16.2M
3
TIF
Tiffany & Co.
TIF
+$15.1M
4
EDU icon
New Oriental
EDU
+$14.8M
5
BZUN
Baozun
BZUN
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 24.23%
2 Healthcare 23.08%
3 Consumer Discretionary 14.73%
4 Financials 8.8%
5 Communication Services 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISV
26
Fiserv Inc
FISV
$27.2B
$12.7M 0.79%
130,458
+39,981
+44% +$4.03M
MU icon
27
Micron Technology
MU
$1.04T
$12.1M 0.75%
234,185
+137,801
+143% +$6.5M
CHD icon
28
Church & Dwight Co
CHD
$23.1B
$11.2M 0.69%
144,301
+64,280
+80% +$4.68M
MRK icon
29
Merck
MRK
$324B
$11.1M 0.69%
150,822
+47,776
+46% +$3.6M
ORCL icon
30
Oracle
ORCL
$331B
$11M 0.68%
198,536
-8,571
-4% -$454K
CVS icon
31
CVS Health
CVS
$137B
$10.7M 0.67%
164,808
+7,263
+5% +$457K
TJX icon
32
TJX Companies
TJX
$170B
$10.6M 0.66%
209,967
+155,763
+287% +$7.82M
BDX icon
33
Becton Dickinson
BDX
$43.1B
$10.6M 0.66%
45,285
-2,040
-4% -$492K
RETA
34
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$10.4M 0.65%
66,750
CSCO icon
35
Cisco
CSCO
$450B
$10.4M 0.64%
221,952
+95,217
+75% +$4.18M
NBIX icon
36
Neurocrine Biosciences
NBIX
$17.7B
$10.3M 0.64%
84,607
-7
-0% -$774
OMCL icon
37
Omnicell
OMCL
$1.86B
$9.83M 0.61%
139,193
+70,132
+102% +$4.8M
STX icon
38
Seagate
STX
$193B
$9.83M 0.61%
203,002
+593
+0.3% +$29.8K
CL icon
39
Colgate-Palmolive
CL
$72.6B
$9.79M 0.61%
133,686
-9,526
-7% -$677K
MDLZ icon
40
Mondelez International
MDLZ
$77.7B
$9.48M 0.59%
185,412
-7,838
-4% -$403K
QDEL icon
41
QuidelOrtho
QDEL
$1.09B
$9.21M 0.57%
41,142
-826
-2% -$129K
CRM icon
42
Salesforce
CRM
$134B
$9.11M 0.57%
48,634
-1,419
-3% -$239K
CHL
43
DELISTED
China Mobile Limited
CHL
$9M 0.56%
267,519
-42,906
-14% -$1.59M
UNH icon
44
UnitedHealth
UNH
$382B
$8.86M 0.55%
30,039
-2,889
-9% -$828K
CERN
45
DELISTED
Cerner Corp
CERN
$8.57M 0.53%
125,004
-1,387
-1% -$95.3K
PFE icon
46
Pfizer
PFE
$140B
$8.51M 0.53%
274,304
-6,224
-2% -$211K
PEP icon
47
PepsiCo
PEP
$186B
$8.41M 0.52%
63,575
-5,939
-9% -$783K
ACWI icon
48
iShares MSCI ACWI ETF
ACWI
$32.6B
$8.15M 0.51%
110,600
-4,300
-4% -$300K
TMO icon
49
Thermo Fisher Scientific
TMO
$211B
$8.14M 0.51%
22,461
-1,057
-4% -$354K
ICUI icon
50
ICU Medical
ICUI
$3.93B
$7.92M 0.49%
43,000
-3,000
-7% -$596K

Similar funds

GAM Holding's Q2 2020 Portfolio in Review

As of Q2 2020, GAM Holding held 386 positions worth $1.61B, up 9.3% from $1.47B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

GAM Holding withdrew a net $148M in Q2 2020, closing 63 positions and reducing 163 holdings. Its most notable exit was JD.com, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GAM Holding opened a new position in Cadence Design Systems worth $6.91M.

  • GAM Holding's largest Q2 2020 buy was Cadence Design Systems: 72,005 shares worth $6.91M.
  • GAM Holding added most to Akamai in Q2 2020, an estimated $9.01M increase.
  • GAM Holding's biggest Q2 2020 reduction was NetEase, cutting an estimated $16.2M.
  • GAM Holding fully exited JD.com in Q2 2020, selling an estimated $18.2M.
  • GAM Holding's ten largest holdings make up 25% of its $1.61B portfolio in Q2 2020.
  • GAM Holding opened 60 new positions and closed 63 in Q2 2020.
  • GAM Holding's portfolio value rose 9.3% quarter-over-quarter to $1.61B.

Based on GAM Holding's 13F filing for Q2 2020, filed 10 Aug 2020.